Trade Resources Industry Views Bayer HealthCare Has Announced That FDA Has Cleared Its CONTOUR Next Link Bgm System

Bayer HealthCare Has Announced That FDA Has Cleared Its CONTOUR Next Link Bgm System

Bayer HealthCare has announced that the US Food and Drug Administration (FDA) has cleared its CONTOUR next link blood glucose monitoring (BGM) system as a component of Medtronic's new MiniMed 530G with Enlite, a breakthrough diabetes management device system with threshold suspend automation.

CONTOUR next link allows seamless integration as a part of the MiniMed 530G insulin pump system transmitting highly accurate blood glucose results wirelessly to the insulin pump.

With Bayer HealthCare's proprietary new blood glucose sensor technology, the CONTOUR next link delivers high accuracy that meets the requirements of ISO 15197:2013.

CONTOUR next link is compatible with Paradigm REAL-Time Revel and Paradigm REAL-Time Insulin pumps, and the Guardian REAL-Time continuous glucose monitoring system, and it is the only BGM labeled for use in the US with the new MiniMed 530G with Enlite.

Additional features of the CONTOUR next link include:

- Wireless transmission of blood glucose test results to Medtronic insulin devices

- Fast and easy bolus dosing and continuous glucose monitoring calibration

- Pass-through feature allows for easy downloading to CareLink software

- Second-Chance sampling allows you to apply more blood to help prevent wasting a test strip

- Connects directly to your computer for instant access to test results and trends, as well as for recharging the battery

- MULTIPULSE accuracy technology from Bayer ensures accurate glucose measurements, even when blood glucose levels are low

- No Coding technology eliminates inaccurate blood glucose results due to user miscoding

- Fast, five-second countdown and tiny 0.6 microliter blood sample

The proprietary electrochemical mediator and meter algorithm utilized in the CONTOUR next link BGM system provides a stable, high signal-to-noise ratio that facilitates accurate determination of blood glucose readings, even at low blood glucose levels.

The new technology also ensures that the system remains accurate under a wide range of storage conditions, corrects for common errors and is not affected by hematocrit or many common interfering substances in the blood (for example acetaminophen, vitamin C).

Source: http://diabetescaredevices.medicaldevices-business-review.com/news/bayer-healthcares-contour-next-link-cleared-for-use-with-medtronics-minimed-530g-with-enlite-221013
Contribute Copyright Policy
Bayer Healthcare's Contour Next Link Cleared for Use with Medtronic's Minimed 530g with Enlite